GE HealthCare: aims to accelerate growth through to 2028

(CercleFinance.com) - On Thursday, GE HealthCare announced its intention to accelerate organic growth over the medium term, before its meeting with the financial community in New York.


The medical imaging equipment manufacturer says it expects to generate average organic sales growth of between 4% and 6% p.a. over 2026 to 2028.

For 2024, the US group says it is aiming for organic growth of between 1% and 2%, while specifying that this should be at the lower end of the range.

Quoted in a press release, Peter Arduini, its CEO, expressed confidence in his group's ability to accelerate its development, notably thanks to the development of its innovation portfolio.

In addition to AI, GEHC sees opportunities for growth in areas such as advanced visualization, patient monitoring and pharmaceutical diagnostics.

Regarding its adjusted EBIT margin, the Chicago-based equipment manufacturer says it is aiming for a figure approaching or exceeding the 20% threshold over 2026-2028.

For 2024, the company reiterates its target of an adjusted operating margin of 15.8% to 18%, representing a 0.7%-0.9% y-o-y improvement.

Following this presentation, the stock - which has risen by 12% this year - was down slightly (-0.5%) in pmt on Thursday morning in NY.


Copyright (c) 2024 CercleFinance.com. All rights reserved.